NHS
Get informed when a big investor buys or sells
+ FollowOvervalued by 52.3% based on the discounted cash flow analysis.
| Market cap | $187.38 Million |
|---|---|
| Enterprise Value | $321.37 Million |
| Dividend Yield | $1.09 (18.19%) |
| Earnings per Share | $0.66 |
| Beta | 0.76 |
| Outstanding Shares | 80,388,140 |
| P/E Ratio | 9.95 |
|---|---|
| PEG | 46.06 |
| Price to Sales | - |
| Price to Book Ratio | 1.98 |
| Enterprise Value to Revenue | 6.51 |
| Enterprise Value to EBIT | 7.68 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | 0.47 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 17.33%▲ 8.99% |
|---|---|
| Total Invested | $86.94M▲ 100.02% |
| Investors Holding | 61▲ 7.00% |
No data
Neuberger Berman High Yield Strategies Fund Inc. is a diversified, closed-end management investment company investing in the high yield debt securities market. The Fund utilizes leverage through the issuance of privately placed notes and preferred stock.